IMMUNOSUPPRESSIVE DRUG THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS-Reference-Cited by-同舟云学术

IMMUNOSUPPRESSIVE DRUG THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS

Published:1994-02 Issue:1 Volume:20 Page:265-299
ISSN:0889-857X
Container-title:Rheumatic Disease Clinics of North America
language:en
Short-container-title:Rheumatic Disease Clinics of North America

Author:

Fox David A.,McCune W. Joseph

Publisher

Elsevier BV

Subject

Rheumatology

Reference270 articles.

1. The in vivo effect of triethylphosphine gold (auranofin), sodium aurothiomalate and azathioprine on natural killer cell activity of patients with rheumatoid arthritis;Abom;Clin Exp Rheumatol,1987

2. Methotrexate therapy in childhood systemic lupus erythematosus;Abud-Mendoza;J Rheumatol,1993

3. Inhibition of leukocyte chemotaxis by immunosuppressive agents. Specific inhibition of lymphocyte chemotaxis by cyclosporine;Adams;Transplantation,1990

4. MR imaging of systemic lupus erythematosus involving the brain;Aisen;AJNR Am J Neuroradiol,1985

5. Immunosuppression by alkylating agents—tolerance induction;Aisenberg;Transplant Proc,1973

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chlorogenic acid rich in coffee pulp extract suppresses inflammatory status by inhibiting the p38, MAPK, and NF-κB pathways;Heliyon;2023-03

2. Treatment of Autoimmune Disease: Established Therapies;The Autoimmune Diseases;2020

3. Systemic Glucocorticoid Therapy in SLE;Dubois' Lupus Erythematosus and Related Syndromes;2013

4. Cytotoxic agents;Comprehensive Dermatologic Drug Therapy;2013

5. Cutaneous lupus erythematosus: Update of therapeutic options;Journal of the American Academy of Dermatology;2011-12